Snapshot from Aug 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech product release

Circle CVI Releases cvi42 v6.5

Analysis based on 7 articles · First reported Aug 05, 2026 · Last updated Aug 05, 2026

Sentiment
10
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The release of cvi42 v6.5 is expected to strengthen Circle CVI's competitive position in the cardiovascular imaging software market by enhancing its product's capabilities and workflow efficiency. This could positively impact the company's market share and revenue growth, though the company is privately held and not directly traded on public markets.

Medical imaging Healthcare technology

Circle Cardiovascular Imaging Inc. (Circle CVI) announced the release of cvi42 v6.5, the latest version of its cardiovascular imaging platform. The update introduces workflow automation, reporting enhancements, and platform improvements designed to help clinicians move more efficiently from acquisition to insight. Key features include automated 4D Flow preprocessing, streamlined CT workflow with editable plaque segmentation and expanded calcium scoring references, improved Quantitative Perfusion with motion correction and polar map display, and reporting updates with direct PDF printing and new vascular CT templates. The company also introduced a Plaque Education Report for referring physicians. The release is available globally to existing customers as part of their current agreement, with feature availability varying by regulatory clearance. Circle CVI is a Canadian-based company founded in 2007, and its cvi42 platform is used in over 2,100 hospitals across more than 90 countries.

priv
Circle CVI is the developer and publisher of cvi42 v6.5, the product release at the center of this event. The new version enhances its platform's features and workflow automation, potentially strengthening its market position and customer satisfaction.
Importance 100.0 Sentiment 20.0
per
Scott Galbari, Chief Product Officer, is quoted in the announcement highlighting the automation of 4D Flow preparation in v6.5. His role is to oversee product development, and this release reflects his team's work.
Importance 30.0 Sentiment 10.0
per
Dr. Kevin Steel, Chief Medical Officer, is quoted emphasizing the clinical benefits of v6.5, including the Plaque Education Report. His endorsement supports the product's clinical credibility.
Importance 30.0 Sentiment 10.0
priv
Signify Research is cited in the announcement for its MRI market outlook, which supports the need for innovation and streamlined workflows in imaging. This reference adds industry context but does not directly affect Signify Research.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.